Element Science Announces Completion of Enrollment in the Jewel IDE Study Evaluating the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)
Retrieved on:
Tuesday, May 23, 2023
Research, Wearables, Mobile Technology, Mobile, Wireless, Technology, Medical Devices, Clinical Trials, Health Technology, Cardiology, Health, Science, Exercise, Arrest, Overalls, Fear, Dick's Picks Volume 20, Sale, SCA, MHS, Heart Rhythm, Patient, Physician, Risk, Principal, Caregiver, Safety, Jewel, Nursing, Medical device, MD
Element Science , an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, announced the completion of enrollment in its Jewel IDE Study (NCT05201495).
Key Points:
- Element Science , an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, announced the completion of enrollment in its Jewel IDE Study (NCT05201495).
- Data from the study will be submitted for U.S. regulatory approval of the Jewel P-WCD to protect patients at temporary elevated risk of sudden cardiac arrest (SCA).
- “We are grateful to the study participants and clinical research professionals for their commitment and contributions to the Jewel IDE Study.
- A patient case from the Jewel IDE Study presented at Heart Rhythm 2023 demonstrated the benefits of the Jewel P-WCD and Mobile App.